Bulletin 2011/10 - European Patent Office
10.02.2013 • Views
Share Embed Flag

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) II.1(1)<br />

AL LT LV MK RO SI<br />

(43) 17.12.2003<br />

(30) 08.12.1997 DE 19754324<br />

20.05.1998 DE 19822549<br />

(54) • Neue Suppositoriumsform mit säureempfindlichem<br />

Wirkstoff<br />

• Novel suppository form comprising an<br />

acid-labile active compound<br />

• Nouvelle forme de suppositoire renfermant<br />

un composé actif acidolabile<br />

(73) Nycomed GmbH, Byk-Gulden-Strasse 2,<br />

78467 Konstanz, DE<br />

(84) BE CH CY DE DK ES FI FR GB IT LI LU MC<br />

(73) Dietrich, Rango, Im Tiergarten 16, 78465<br />

Konstanz, DE<br />

(84) AT GR IE NL PT SE<br />

(72) Linder, Rudolf Dr., 78464 Konstanz, DE<br />

Dietrich, Rango Dr., 78465 Konstanz, DE<br />

(74) Kratzer, Bernd, et al, Nycomed GmbH<br />

Postfach <strong>10</strong> 03 <strong>10</strong>, 78403 Konstanz, DE<br />

(62) 98966609.4 / 1 037 607<br />

(51) A61K 9/<strong>10</strong>7 (11) 2 117 5<strong>10</strong> B1<br />

A61K 38/13<br />

(25) Fr (26) Fr<br />

(21) 08761739.5 (22) 04.01.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 18.11.2009<br />

(86) FR 2008/000015 04.01.2008<br />

(87) WO 2008/099084 2008/34 21.08.2008<br />

(30) 09.01.2007 FR 0700127<br />

(54) • PARENTERALE PHARMAZEUTISCHE<br />

ZUSAMMENSETZUNG UND VERFAHREN<br />

ZU DEREN HERSTELLUNG<br />

• PARENTERAL PHARMACEUTICAL COM-<br />

POSITION AND METHOD FOR PREPARING<br />

THE SAME<br />

• COMPOSITION PHARMACEUTIQUE<br />

PARENTÉRALE ET SON PROCEDE DE<br />

PREPARATION.<br />

(73) Physica Pharma, Château Bersol, Bat. 2, 218/<br />

228, avenue du Haut-Lévêque, 33600 Pessac,<br />

FR<br />

(72) BROUSSAUD, Olivier, F-33000 Bordeaux, FR<br />

POUGNAS, Jean-Luc, F-33500 Libourne, FR<br />

CALVET, Nicolas, F-33200 Bordeaux, FR<br />

(74) Noel, Chantal Odile, et al, Cabinet Orès 36,<br />

rue de St Pétersbourg, 75008 Paris, FR<br />

(51) A61K 9/12 (11) 2 2<strong>10</strong> 588 B1<br />

A61K 8/04 A61K 8/368<br />

A61K 8/37 A61K 8/34<br />

A61K 8/49 A61K 8/73<br />

A61K 8/86 A61P 17/04<br />

A61P 17/06<br />

A61Q 19/00<br />

A61P 17/<strong>10</strong><br />

(25) En (26) En<br />

(21) 08022333.2 (22) 23.12.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

BA<br />

(43) 28.07.20<strong>10</strong><br />

(54) • Schäumbare Zusammensetzung, die im<br />

Wesentlichen frei von pharmazeutisch<br />

aktiven Inhaltsstoffen ist, zur Behandlung<br />

der menschlichen Haut<br />

• Foamable composition essentially free of<br />

pharmaceutically active ingredients for the<br />

treatment of human skin<br />

• Composition moussante essentiellement<br />

dépourvue d'ingrédients actifs de manière<br />

pharmaceutique pour le traitement de la<br />

peau humaine<br />

(73) Intendis GmbH, Max-Dohrn-Strasse <strong>10</strong>,<br />

<strong>10</strong>589 Berlin, DE<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(72) Graupe, Klaus, Dr., D-<strong>10</strong>717 Berlin, DE<br />

Städtler, Gerald, D-12161 Berlin, DE<br />

(74) Gebauer, Olaf, et al, Bayer HealthCare AG<br />

Law and <strong>Patent</strong>s <strong>Patent</strong>s & Licensing Building<br />

Q18, 51683 Leverkusen, DE<br />

(51) A61K 9/16 (11) 1 499 297 B1<br />

A61K 9/20 A61K 31/40<br />

A61P 3/06<br />

(25) En (26) En<br />

(21) 02702654.1 (22) 13.03.2002<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

AL LT LV MK RO SI<br />

(43) 26.01.2005<br />

(86) IB 2002/000736 13.03.2002<br />

(87) WO 2002/072073 2002/38 19.09.2002<br />

(30) 14.03.2001 SI 200<strong>10</strong>0069<br />

(54) • KALZIUMATORVASTATIN ENTHALTENDE<br />

ARZNEIFORMULIERUNG<br />

• PHARMACEUTICAL FORMULATION COM-<br />

PRISING ATORVASTATIN CALCIUM<br />

• FORMULATION COMPRENANT DE<br />

L'ATORVASTATINE CALCIQUE<br />

(73) LEK Pharmaceuticals d.d., Verovskova 57,<br />

1526 Ljubljana, SI<br />

(72) KERC, Janez, <strong>10</strong>00 Ljubljana, SI<br />

MATEJA, Salobir, <strong>10</strong>00 Ljubljana, SI<br />

BAVEC, Sasa, <strong>10</strong>00 Ljubljana, SI<br />

(74) TBK-<strong>Patent</strong>, Bavariaring 4-6, 80336<br />

München, DE<br />

(60) <strong>10</strong>183122.0 / 2 263 655<br />

(51) A61K 9/16 (11) 1 701 703 B1<br />

(25) En (26) En<br />

(21) 04806432.3 (22) 20.12.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

(43) 20.09.2006<br />

(86) IB 2004/004260 20.12.2004<br />

(87) WO 2005/065656 2005/29 21.07.2005<br />

(30) 31.12.2003 US 533848 P<br />

(54) • STABILISIERTE PHARMAZEUTISCHE<br />

FESTE ZUSAMMENSETZUNGEN VON<br />

ARZNEIMITTELN MIT GERINGER LÖS-<br />

LICHKEIT, POLOXAMEREN UND STABILI-<br />

SIERENDEN POLYMEREN<br />

• STABILIZED PHARMACEUTICAL SOLID<br />

COMPOSITIONS OF LOW-SOLUBILITY<br />

DRUGS, POLOXAMERS AND STABILIZING<br />

POLYMERS<br />

• COMPOSITIONS PHARMACEUTIQUES<br />

SOLIDES STABILISEES DE MEDICAMENTS<br />

A FAIBLE SOLUBILITE, POLOXAMERES ET<br />

POLYMERES STABILISANTS<br />

(73) Bend Research, Inc., 64550 Research Road,<br />

Bend, OR 97701-8599, US<br />

(72) CREW, Marshall David, Bend, OR 97701, US<br />

SHANKER, Ravi Mysore, Groton, CT 06340,<br />

US<br />

SMITHEY, Daniel Tod, Bend, OR 97701, US<br />

MILLER, Warren Kenyon, Bend, OR 97701,<br />

US<br />

FRIESEN, Dwayne Thomas, Bend, OR 97702,<br />

US<br />

(74) Albrecht, Thomas, et al, Kraus & Weisert<br />

<strong>Patent</strong>- und Rechtsanwälte Thomas-Wimmer-Ring<br />

15, 80539 München, DE<br />

A61K 9/16 → (51) A61K 9/58<br />

(51) A61K 9/20 (11) 2 178 512 B1<br />

C07D 213/42<br />

A61K 45/06<br />

A61K 31/395<br />

(25) En (26) En<br />

(21) 08771565.2 (22) 20.06.2008<br />

536<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>10</strong>/<strong>2011</strong>) 09.03.<strong>2011</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 28.04.20<strong>10</strong><br />

(86) US 2008/067629 20.06.2008<br />

(87) WO 2009/002826 2009/01 31.12.2008<br />

(30) 22.06.2007 US 945691 P<br />

(54) • TABLETTIERTE ATAZANAVIRHALTIGE<br />

ZUSAMMENSETZUNGEN<br />

• TABLETED COMPOSITIONS CONTAINING<br />

ATAZANAVIR<br />

• COMPOSITIONS EN COMPRIMÉS CONTE-<br />

NANT DE L'ATAZANAVIR<br />

(73) Bristol-Myers Squibb Company, Route 206<br />

and Province Line Road, Princeton, NJ<br />

05843-4000, US<br />

(72) KOO, Otilia May Yue, New Brunswick, New<br />

Jersey 08903, US<br />

NIKFAR, Faranak, New Brunswick, New<br />

Jersey 08903, US<br />

DIAZ, Steven, Martinsville, New Jersey<br />

08836, US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte<br />

Sternwartstrasse 4, 81679 München, DE<br />

A61K 9/20 → (51) A61K 9/16<br />

A61K 9/20 → (51) A61K 9/46<br />

A61K 9/20 → (51) A61K 9/58<br />

A61K 9/26 → (51) A61K 9/58<br />

(51) A61K 9/46 (11) 1 708 685 B1<br />

A61K 9/20<br />

(25) En (26) En<br />

(21) 04815715.0 (22) 30.12.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(43) 11.<strong>10</strong>.2006<br />

(86) US 2004/043702 30.12.2004<br />

(87) WO 2005/065318 2005/29 21.07.2005<br />

(30) 31.12.2003 US 533619 P<br />

04.<strong>10</strong>.2004 US 615665 P<br />

04.<strong>10</strong>.2004 US 615785 P<br />

(54) • BRAUSEFORMEN VON OPIATEN ZUR<br />

ORALEN ANWENDUNG UND VERFAHREN<br />

ZUR VERABREICHUNG VON OXYCODON<br />

• EFFERVESCENT ORAL OPIATE DOSAGE<br />

FORMS AND METHODS OF ADMINISTER-<br />

ING OXYCODONE<br />

• FORMES GALENIQUES D'OPIATES ORA-<br />

LES EFFERVESCENTES ET PROCEDES<br />

D'ADMINISTRATION DE L'OXYCODONE<br />

(73) CIMA LABS INC., <strong>10</strong>000 Valley View Road,<br />

Eden Prairie, MN 55344-9361, US<br />

(72) MOE, Derek, Maple Grove, MN 55311, US<br />

(74) Maiwald <strong>Patent</strong>anwalts GmbH, Elisenhof<br />

Elisenstrasse 3, 80335 München, DE<br />

A61K 9/50 → (51) A61K 9/58<br />

(51) A61K 9/58 (11) 2 098 225 B1<br />

A61K 9/50 A61K 9/16<br />

A61K 9/26 A61K 9/20<br />

(25) En (26) En<br />

(21) 09007900.5 (22) 04.01.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 09.09.2009<br />

(30) 06.01.2005 US 641807 P<br />

<strong>10</strong>.01.2005 US 642619 P<br />

(54) • Geschmacksunterdrückungssystem für<br />

nicht weichgemachte Arzneimittel

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!